Discover the full record of transactions filed by 김명진, Directeur. Officer active across 3 companies, notably HLB바이오스텝. Aggregated, 17,943 reports have been recorded. Activity tracked since 4 March 2026. The latest transaction was disclosed on 4 March 2026 (Purchase). Regulator: DART (FSS). All data is accessible without signup.
Kim Myung-Jin is a Director at HLB BioStep, a company active in the biopharmaceutical sector. In this role, he is involved in strategic decision-making and the development of new products. His technical expertise is valuable for the company's innovation.